We’re excited to share that Ellis Bio will be attending the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from May 30 to June 3! 🎗️
As leaders in epigenetics research tools, we’re advancing bisulfite conversion technology to better serve cancer researchers and clinicians working to decode the methylation landscape of tumors. Whether you’re developing diagnostics, profiling cancer subtypes, or exploring epigenomic biomarkers, we’d love to show you how our latest innovations can elevate your workflows.
Why Meet with Ellis Bio at ASCO?
-Learn about our SuperMethyl™ kits, engineered for higher DNA recovery and reduced degradation
-Discuss your current methylation analysis challenges with our scientific team
-Explore collaboration, beta testing, or custom development opportunities
📍 Let’s schedule a time to meet during the conference and explore how we can support your epigenetic and oncology research.